Is obesity an inflammatory disease?

Area of Science:

• Metabolic Surgery
• Inflammation Research
• Obesity Studies

Background:

• Obesity is linked to elevated inflammation markers like IL-6 and TNF-alpha.
• These inflammatory markers are associated with conditions such as diabetes, hypertension, and stroke.
• Obesity is characterized as a low-grade inflammatory disease.

Purpose of the Study:

• To investigate the impact of Roux-en-Y gastric bypass (RYGB) on inflammation markers.
• To assess changes in gene expression in key metabolic and fat tissues post-RYGB.
• To confirm obesity as an inflammatory condition.

Main Methods:

• Obesity was induced in Sprague Dawley rats using a high-energy diet (HED).
• Three groups were studied: RYGB, sham-operated pair-fed, and sham-operated ad libitum HED, alongside a chow-fed control group.
• Post-operation, body weight, fat tissue mass, and levels of IL-6, TNF-alpha, and corticosterone were measured. Gene expression profiling was performed on the arcuate nucleus and subcutaneous abdominal fat (SAF).

Main Results:

• RYGB surgery resulted in significant weight loss compared to sham-operated groups.
• A decrease in mesenteric and subcutaneous abdominal fat weight was observed post-RYGB.
• Inflammation markers (IL-6, TNF-alpha, corticosterone) and associated gene expression in fat tissues were reduced after RYGB.

Conclusions:

• Roux-en-Y gastric bypass surgery effectively reduces biochemical markers of inflammation.
• The findings support the classification of obesity as an inflammatory condition.
• RYGB may mitigate obesity-related inflammation and associated health risks.